MEDINET Co., Ltd. (2370) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Peptidream, Inc.

Cyfuse Biomedical KK

MEDINET Co., Ltd.

Oncolys BioPharma, Inc.

StemCell Institute

OncoTherapy Science, Inc.

Carna Biosciences, Inc.

Chiome Bioscience, Inc.

SUSMED, Inc.

GNI Group Ltd.

Stella Pharma Corp.

Why is MEDINET Co., Ltd. ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Net Sales has grown by an annual rate of 4.64% over the last 5 years

Flat results in Mar 26

INTEREST(HY) At JPY 2.9 MM has Grown at 57,920%
CASH AND EQV(HY) Lowest at JPY 5,779.52 MM
DEBT-EQUITY RATIO (HY) Highest at -81.92 %

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -6.90%, its profits have fallen by -3.3%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -6.90% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MEDINET Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

MEDINET Co., Ltd.

-100.0%

-0.76

52.81%

Japan Nikkei 225

69.64%

2.62

26.55%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.64%

EBIT Growth (5y)

-8.30%

EBIT to Interest (avg)

-696.12

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.87

Sales to Capital Employed (avg)

0.17

Tax Ratio

0.31%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.41

EV to EBIT

-3.78

EV to EBITDA

-4.06

EV to Capital Employed

9.38

EV to Sales

6.88

PEG Ratio

Dividend Yield

ROCE (Latest)

-248.32%

ROE (Latest)

-39.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -150.93% (YoY

NET SALES(Q)

At JPY 232.88 MM has Grown at 18.35%

OPERATING PROFIT(Q)

Highest at JPY -234.42 MM

OPERATING PROFIT MARGIN(Q)

Highest at -100.66 %

PRE-TAX PROFIT(Q)

Highest at JPY -179.87 MM

NET PROFIT(Q)

Highest at JPY -180.17 MM

EPS(Q)

Highest at JPY -0.78

-12What is not working for the Company

INTEREST(HY)

At JPY 2.9 MM has Grown at 57,920%

CASH AND EQV(HY)

Lowest at JPY 5,779.52 MM

DEBT-EQUITY RATIO (HY)

Highest at -81.92 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 9.31 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.57 times

Here's what is working for MEDINET Co., Ltd.

Net Sales

At JPY 232.88 MM has Grown at 18.35%

over average net sales of the previous four periods of JPY 196.77 MM

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit

Highest at JPY -234.42 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Operating Profit Margin

Highest at -100.66 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at JPY -179.87 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY -180.17 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY -0.78

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost

Fallen by -150.93% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MEDINET Co., Ltd.

Interest

At JPY 2.9 MM has Grown at 57,920%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv

Lowest at JPY 5,779.52 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -81.92 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 9.31 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.57 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio